Herbal therapeutics for cancer control: an overview

B Taliya Kure; A Muhammad Mayaki; G Yemisi Oyinloye; J Michael Dauda; A Wemimo Ayeni; Sayyadi Abdulkaddir

doi:10.30574/gscbps.2019.9.1.0172

Authors

B Taliya Kure Department of Biochemistry, Federal University of Technology Minna, Nigeria.
A Muhammad Mayaki Department of Biochemistry, Federal University of Technology Minna, Nigeria.
G Yemisi Oyinloye Department of Biochemistry, Federal University of Technology Minna, Nigeria.
J Michael Dauda Department of Biochemistry, Federal University of Technology Minna, Nigeria.
A Wemimo Ayeni Department of Biochemistry, Federal University of Technology Minna, Nigeria.
Sayyadi Abdulkaddir Department of Biochemistry, Federal University of Technology Minna, Nigeria.

DOI:

https://doi.org/10.30574/gscbps.2019.9.1.0172

Keywords:

Cancer, Plants, Conventional therapy, Phytochemicals, Herbal therapy

Abstract

Cancer is said to be an uncontrolled cell proliferation or metastasis of abnormal cells in the body. Modern chemotherapy, radiotherapy, and other antineoplastic regimens have limitation of multiple drug resistance (MDR) and high rate of cancer recurrence after initial chemotherapy treatments. Natural products (NPs) have been a historically rich source of biologically active compounds for the pharmaceutical industry. These natural products serve as rich sources of bioactive metabolites including alkaloids, phenol compounds, and monoterpenes. In addition to these, compounds such as vinblastine, vincristine, curcumin, Taxol, boswellic acid, and umbelliprenin and compounds such as quercetin, catechin, cucurbitacin, kaempferol, thymol, carvacrol, 1 and 1, 8-cineole, a-pinene, myrecene, and b-sitosterol have been reported for anticancer effects. These compounds have antioxidant properties, and inhibition of damage to DNA, cell cycle arrest (especially at the G2/M), induction of apoptosis, inhibition of angiogenesis in tumor cells, and its anticancer effects are well reported. Using natural products for the control and management of cancer is an assurance of a safe, cost effective and complete treatment for cancer with no significant physical side effects that crop up with other treatment options for cancer treatment.

Metrics

Metrics Loading ...

References

Kaufman D and Chabner BA. (1996). Clinical strategies for cancer treatment: The role of drugs. In: Chabner BA, Longo DL, editors. Cancer Chemotherapy and Biotherapy: Principles and Practice. Philadelphia: Lippincott-Raven, 1-16.

Kasthuri OR and Ramesh B. (2008). Toxicity Studies on Leaf Extracts of Alternanthera brasiliana (L.) Kuntze and Alternanthera bettzickiana (Regel) Voss. Journal of Applied Pharmaceutical Science, 8(10), 082-089.

Desai AG, Ghulam NQ, Ramesh KG, Mahmoud E, Jaswant S, Ajit KS, Yashbir SB, Subhash CT and Hari KB. (2008). Medicinal Plants and Cancer Chemoprevention. Current Drug Metabolism, 9(7), 581–591.

World Health Organization (2005). Preventing Chronic Diseases: A Vital Investment. Geneva, Switzerland.

Rajamanickam B, Kuo Ann L, Richard Y and Kheng-Wei Y. (2012). Cancer and Radiation Therapy: Current Advances and Future Directions. International Journal of Medical Sciences, 9(3), 193-199.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR and Coltman C. (2001). SELECT: the next prostrate cancer prevention trial. Selenium and vitamin E cancer prevention trial. Journal of Urology, 166, 1311 – 1315.

Lawal B, Shittu OK, Oibiokpa FI, Berinyuy EB and Muhammed,H. (2016). African natural products with potential antioxidants and hepatoprotectives properties: a review, Clinical Phytoscience, 2, (23), 1-66.

Bashir L, Shittu OK, Sani S, Busari MB and Adeniyi KA. (2015).African Natural Products with Potential Antitrypanosoma Properties: A Review. International Journal of Biochemistry Research & Review, 7(2), 45-79.

Lawal B, Shittu OK, Kabiru AY, Jigam AA, Umar MB, Berinyuy EB and Alozieuwa BU. (2015). Potential antimalarials from African natural products: A review. J. Intercult Ethnopharmacology, 4(4), 318-343.

Govind P. (2009). An Overview on Certain Anticancer Natural Products. Journal of Pharmacy Research, 2(12), 1799-1803.

Kooti W, Karo S, Masoud B, Majid A, Fatemeh S, Bijan N and Hadi Z. (2017). Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study. Journal of Evidence-Based Complementary & Alternative Medicine, 22(4), 982-995.

Taylor WF and Jabbarzadeh E. (2017). The use of natural products to target cancer stem cells; American Journal of Cancer Research, 7(7), 1588-1605.

Zhang Q, Feng Y and Kennedy D. (2017). Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this? Cellular and Molecular Life Sciences, 74, 777-801.

Phillips TM, McBride WH and Pajonk F. (2006). The response of CD24 (-/low)/CD44+ breast cancer initiating cells to radiation. Journal of the National Cancer Institute, 98, 1777-1785.

Gurnani N, Mehta D, Gupta M and Mehta BK. (2014). Natural Products: Source of Potential Drugs. African Journal of Basic & Applied Sciences, 6 (6), 171-186.

Gupta AK and Tandon N. (2004). Reviews on Indian Medicinal Plants. New Delhi: Indian Council of Medical Research.

Reddy L, Odhav B and Bhoola KD. (2003). Natural products for cancer prevention: a global perspective. Pharmacology & Therapeutics, 99, 1–13.

Cragg GM, Kingston DGI and Newman DJ. (2012). Anticancer Agents from Natural Products, ed 2. Boca Raton, CRC/Taylor & Francis.

Chashoo G, Singh SK and Sharma PR. (2011). A propionyloxy derivative of 11-keto-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition. Chemical Biology Interaction, 189, 60-71.

Ruiz-Torres V, Encinar JA, Herranz-López M, Pérez-Sánchez A, Galiano V, Barrajón-Catalán E and Micol V.(2017). An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs. Molecules, 22, 1037.

Roussi F, Guéritte F and Fahy J. (2012). The vinca alkaloids; in Cragg GM, Kingston DGI, Newman DJ (eds): Anticancer Agents from Natural Products, ed 2. Boca Raton, CRC/Taylor & Francis, 177–198.

Song Y, Sun H, Zhang A, Yan G, Han Y and Wang X. (2014). Plant-derived natural products as leads to anti-cancer drugs. Journal of Medicinal Plant and Herbal Therapy Research, 2, 6-15.

Lee KH and Xiao Z. (2012). Podophyllotoxins and analogs; in Cragg GM, Kingston DGI, Newman DJ (eds): Anticancer Agents from Natural Products, ed 2. Boca Raton, CRC/Taylor & Francis, 95–122.

Hartwell JL. (1982). Plants Used against Cancer. Lawrence, Quarterman.

Kingston DGI. (2012). Taxol and its analogs; in Cragg GM, Kingston DGI, Newman DJ (eds): Anticancer Agents from Natural Products, ed 2. Boca Raton, CRC/Taylor & Francis, 123–175.

Bora KS and Sharma A. (2011). The genus Artemisia: a comprehensive review. Pharmaceutical Biology, 49, 101-109.

Asgarpanah J and Ariamanesh A. (2015). Phytochemistry and pharmacological properties of Myrtus communis L. Indian Journal of Traditional Knowledge, 14, 82-87.

Akrout A, Gonzalez LA and Hajer El J. (2011). Antioxidant and antitumor activities of Artemisia campestris and Thymelaea hirsuta from southern Tunisia. Food Chemistry Toxicology, 49(2), 342-47.

Lawal B, Shittu OK, Oibiokpa IF, Mohammed H, Umar SI and Haruna GM. (2016). Antimicrobial evaluation, acute and sub-acute toxicity studies of Allium sativum, Journal of Acute Disease, 5(4), 296–301.

Milner JA. (2001). A historical perspective on garlic and cancer. Journal of Nutrition, 131(3), 1027s-1031s.

Colic M, Vucevic D, Kilibarda V, Radicevic N and Savic M., (2002). Modulatory effects of garlic extracts on proliferation of T-lymphocytes in vitro stimulated with concanavalin A. Phytomedicine, 9, 117-124.

Sharaf M, El-Ansari MA and Saleh NA. (2000). New flavonoids from Avicennia marina. Fitoterapia, 71, 274-277.

Momtazi BA, Behbahani M and Sadeghi-Aliabadi H. (2001). Evaluation of cytotoxic effect of some extracts of Avicennia marina against MDA-MB231 human breast cancer cell line. Pharmaceutical Sciences, 16, 229-238.

Moussaieff A and Mechoulam R. (2009). Boswellia resin: review of in-vitro, in-vivo and clinical trials. Journal of Pharmaceutical Pharmcology, 61, 1281-1293.

Siddiqui MZ. (2011). Boswellia serrata, a potential anti-inflammatory agent: an overview. Indian Journal of Pharmaceutical Science, 73, 255-261.

Forouzandeh S, Naghsh N, Salimi S and Jahantigh D. (2014). Cytotoxic effect of Boswellia serrata hydroalcholic extract on human cervical carcinoma epithelial cell line. Medical Laboratory Journal, 8(1), 7-13.

Huang MT, Badmaev V, Ding Y, Liu Y, Xie JG and Ho CT. (2000). Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors, 13, 225-230.

Poeckel D and Werz O. (2006). Boswellic acids: biological actions and molecular targets. Current Medical Chemistry, 13, 3359-3369.

Chattopadhyay I, Bisshall be K, Bandyopadhyay U and Banerjee RK. (2004).Turmeric and curcuminBiological actions and medicinal applications. Curr Sci, 87, 44-50.

Perko T, Ravber M, Knez Z and Skerget M. (2015). Isolation, characterization and formulation of curcuminoidsand in vitro release study of the encapsulated particles. J Supercrit Fluids, 103, 48-54.

Kalpravidh RW, Siritanaratkul N, Insain P, et al. (2010). Improvement in oxidative stress and antioxidant parameters in b-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem, 4342-4429.

Panahi Y, Saadat A, Beiraghdar F, Nouzari SMH, Jalalian HR and Sahebkar A. (2014). Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: a randomized double-blind placebo-controlled trial. J Funct Foods, 6, 615-622.

Zhan PY, Zeng XH, Zhang HM and Li HH. (2011). High-efficient column chromatographic extraction of curcumin from Curcuma longa. Food Chem, 129, 700-703.

Jurenka JS: Anti-inflammatory properties of curcumin, a major constituent of Curcima longa: A review of preclinical and clinical research. Altern Med Rev 2009, 14, 141-153.

Korrapati S, Kurra P and Puttugunta S. (2016). Natural and Herbal Remedies for Cancer Treatment. Inventi Impact: Planta Activa, (4), 140-147.